AXGN vs ISRG

For growth investors, Intuitive Surgical, Inc.

(ISRG) is the stronger pick with 20. 5% revenue growth year-over-year, versus 20. 2% for AxoGen, Inc. (AXGN). Intuitive Surgical, Inc. (ISRG) offers the better valuation at 57. 4x trailing P/E (43. 7x forward), making it the more compelling value choice. Analysts rate AxoGen, Inc. (AXGN) a "Buy" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Intuitive Surgical, Inc.

is actually cheaper at 43. 7x.

Over the past 5 years, AxoGen, Inc.

(AXGN) delivered a total return of +96. 8%, compared to +60. 9% for Intuitive Surgical, Inc. (ISRG). Over 10 years, the gap is even starker: AXGN returned +669. 6% versus ISRG's +556. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), AxoGen, Inc.

(AXGN) is the lower-risk stock at 0. 90β versus Intuitive Surgical, Inc. 's 1. 02β — meaning ISRG is approximately 13% more volatile than AXGN relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 15% for AxoGen, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Intuitive Surgical, Inc.

(ISRG) is pulling ahead at 20. 5% versus 20. 2% for AxoGen, Inc. (AXGN). On earnings-per-share growth, the picture is similar: Intuitive Surgical, Inc. grew EPS 22. 6% year-over-year, compared to -47. 8% for AxoGen, Inc.. Over a 3-year CAGR, AXGN leads at 17. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Intuitive Surgical, Inc.

(ISRG) is the more profitable company, earning 28. 4% net margin versus -7. 0% for AxoGen, Inc. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -3. 5% for AXGN. At the gross margin level — before operating expenses — AXGN leads at 74. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Intuitive Surgical, Inc.

(ISRG) trades at 43. 7x forward P/E versus 89. 4x for AxoGen, Inc. — 45. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ISRG: 37. 8% to $622. 60.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, AxoGen, Inc.

(AXGN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 90), +669. 6% 10Y return). Both have compounded well over 10 years (AXGN: +669. 6%, ISRG: +556. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.